Trial Profile
Pivotal phase I trial of captisol-enabled docetaxel (ML 061) in patients with cancer
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 26 Nov 2012
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary)
- Indications Cancer; Solid tumours
- Focus Registrational; Therapeutic Use
- 26 Nov 2012 New trial record